Extensive investigations dating back to 1932 (1, 2, 3) have shown that, in experimental animals, it is possible to produce cutaneous calcinosis reminiscent of calcifying scieroderma (the "sclérodermie calcaire" of French dermatologists) with certain calcification-promoting compounds, such as parathyroid hormone or dihydrotachysterol (DHT). However, irrespective of the evocative agent, the cutaneous lesions could not serve as practical models of disease, because they developed only on the scalp and neck (not wherever the experimenter wanted to induce them), occurred irregularly, were exclusive to very young animals, and the accompanying mortality was high. Still, these observations were repeatedly confirmed by others and eventually induced Leriche and co-workers (4, 5, 6) to remove the parathyroids in patients with severe scieroderma. The results of this operation were rather inconstant, but in some cases marked improvement did occur, so that further work designed to improve our experimental model was thought to be desirable.
tions are identical or even fundamentally related, there can be no doubt that the experimental disease closely resembles clinical cutaneous caleinosis and, therefore, can serve as a practical laboratory model of the latter.
A great deal of work is currently under way to determine the factors able to promote or prevent experimental cutaneous calcinosis; it has already been possible to demonstrate that the condition can be suppressed by suitable treatment, at the "critical period" of its development, with the lathyrogenic substance aminoacetonitrile, or "AAN" (10) . Preliminary experiments suggested that the oral administration of certain electrolytes known to enhance soft-tissue calcification (e.g., phosphates, calcium salts) greatly sensitizes the DHT-treated rat for the production of cutaneous calcification by the topical trauma of epilation. It was found, furthermore, that in such experiments the intracutaneous or subcutaneous injection of small amounts of ferric chloride is considerably more effective than epilation in causing a topical predisposition for calcium deposition.
The into 9 equal groups and treated as indicated in Table I .
Vitamin D2 (Frosst) was administered by stomach tube, in doses of 0.2 mg., 1 mg., or 5 mg., in 0.5 ml. of Mazola oil, once daily during the first 4 days.
Monobasic sodium phosphate (NaH2PO4) and calcium acetate were given throughout the experiment in doses of 1 mM in 2 ml. of water, twice daily, by stomach tube.
On the 4th day, which was the critical time of vitamin D2 overdosage, the hair was removed by plucking over the calvarium. Two injections of FeCl3 were given in an area of shaved skin on the back, one consisting of 0.1 mg. intracutaneously and the other of 1 mg. subcutaneously, each in 0.2 ml. of water.
Autopsy was performed after 10 days of treatment. The mean grades of cutaneous calcinosis listed in the table are based on examination of the skin 4 days after plucking and at autopsy. The severity of the lesions was assessed in terms of an arbitrary scale of 0 to 3 (0 = no lesion, 1 = barely detectable lesion, 2 = moderate lesion, 3 = most severe lesion); the mean grades at autopsy are listed (with standard errors) in the table.
For the purpose of histologic studies, specimens of the skin, heart, aorta, and kidney were fixed in alcohol-formol, for the subsequent demonstration of calcium (von Kóssa and eelestin blue technies) or iron (Prussian blue technic), and in picric-acidsaturated Susa solution for staining with tbe PAS technic.
RESULTS
Readings of cutaneous calcinosis made 4 days after trauma were almost the same as the final readings (given in Table I ), except in Group S.
In this group, which received 1 mg. injections of vitamin D2 and Ca-acetate, the lesion developed more slowly, but at the time of the final reading, was more severe than in other groups receiving comparable amounts of vitamin D2.
Group 3, which received 5 mg. of vitamin D2 daily during the first 4 days, showed particularly severe cutaneous caleinosis, which, unlike in other groups, was not confined to the plucked area or the injection site of FeC13.
Intense ealcinosis was seen in Group 5 where a smaller dose of vitamin D2 (1 mg.) was given in combination with NaH2PO4 . Most of the animals in this group showed marked calcification of the tongue.
The highest mortality occurred among the rats treated with the highest doses of vitamin D2 (5 mg.) and calcium or phosphate. All rats in Group 6 died on the 4th or 5th day of treatment with vitamin D2 + Na}IaPO4. In Group 9, where they received the highest doses of vitamin D2 + Caacetate, the rats died from the 4th to the 7th day of the experiment. Because of this early mortality, the extremely severe skin lesions in these two groups could not be compared with the others at the time of the final readings; hence, they are not listed in the table.
Cardiovascular and renal calcification ran roughly parallel to the cutaneous calcification.
Histologic examination of the skin specimens revealed that, in these vitamin-D2-treated rats, Systemic Treatment All animals were traumatized locally by plucking the hair over the calvarium on the 4th day. Vitamin D2 was given daily for 4 days. Ca-acetate and NaH2PO4 were given throughout the experiment. FeCl3 injections were given once on the 4th day. The readings of cutaneous caleinosis represent the condition on the 11th day.
the microscopically detectable lesions exhibited structural characteristics essentially similar to those previonsly described as typical of the cutaneous calcinosis induced by DHT and epilation (9); hence, we need not discuss them here in detail.
In essence, initially there is calcium deposition in the form of small granules along the course of the collagen fibers, with considerable swelling of the latter, edema, a mild inflammatory response, and eventually, massive calcification in the derma, the hair follicles, and the subcutis. In later stages, the calcium deposits tend to be eliminated by exulccration. Eventually, the lesion heals, vir- Figure 3 is here stained with celestin blue. Note again the selective calcification of the margin of the calcified regions and the much greater clarity of structural detail that is due to the fact that, unlike with the von Kdssa technic, staining is here strictly limited to the affected structural elements and there is no diffuse "bleeding" of the dye into the surroundings (Celestin blue X 90). Figure 5 , iron impregnation is limited to the cytoplasm of the fibroblasts and to some phagocytes, while the collagen fibers remain unaffected (Prussian blue X 368).
FIG. 4. The region shown in
calcification produced by an agent were in no way correlated, in rats treatcd with vitamin P1 or PUT. Indeed, very strong inflammatory irritants (e.g., croton oil) or agents conducive to topical necrosis (intense heat or cold) were singularly ineffective in precipitating local calcification.
In our experiments-as in the clinical calcifying scleroderma-the mineral depositions are accompanied by sclerosis; sclerotic changes are also frequent accompaniments of iron deposition without calcification (for example, the hepatic and pancreatic sclerosis in hemochromatosis). Hence, further studies along these lines would appear to hold promise.
Finally, it should be pointed out that although vitamin P1 is much more effective than PUT in the cure of rickets, the reverse is true of the cutaneous calcinosis-producing action of these two compounds. Exact comparative determinations of activity have not yet been carried out, but it may be said that, in our earlier studies with DHT, we obtained sensitization to cutaneous calcinosis with approximately one-tenth of the minimum dose of vitamin P2 that proved effective in the experiments reported here.
SUMMARY
Experiments on rats indicate that, following oral administration of vitamin D1, epilation of a skin region suffices to produce topical cutaneous calcinosis with sclerosis. Intra-or subcutaneous injection of dilute ferric chloride proved even much more effective in this respect.
Oral administration of NaH1PO4 or calcium acetate greatly augmented the ability of vitamin P1 to sensitize for the induction of cutaneous calcinosis under these experimental conditions.
The same electrolytes also augmented the ability of vitamin P1 overdosage to produce calcium depositions in the cardiovascular system and the kidney.
In rats not sensitized by vitamin P1 supplements, similar topical treatment of the skin with FcC13 induced a histochemically demonstrable, rather selective iron deposition in the regional macrophagcs and collagen fibers. This was not associated with any excessive calcium deposition.
Injection of vitamin P1 or PUT into the skin causes no local calcinosis; hence, the effect of these compounds appears to be indirect and not 
